Rolinsatamab
Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13. Rolinsatamab chimeric antigen receptor sequence T cells. Rolinsatamab can be used to prevent and treat immune diseases.
Product Specifications
CAS Number
2095467-30-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A136756 100 µL
Anti-ATTR/Transthyretin amyloidosis Antibody (NI-301) Biosimilar (Monoclonal, IgG)
Ask
View Details 
M4700-05B-APC 100 µL
Mucin 1 (MUC1 Glycoprotein, MUC-1, Breast Carcinoma Associated Antigen DF3, CA 15-3, Carcinoma Associated Mucin, CD227, DF3, EMA, Episialin, Epithelial Basement Membrane Antigen, Epithelial Membrane Antigen, Epithelial Mucin Tandem Repeat Sequence, H23 Antigen, H23AG, HGNC:7508, MAM6, Mucin 1 Precursor, Mucin 1 Transmembrane, Peanut-reactive Urinary Mucin, PUM, Polymorphic Epithelial Mucin, PEM, PEMT, Tumor Associated Epithelial Membrane Antigen, Tumor Associated Mucin) (APC) discontinued
Ask
View Details 
MBS6300030-01 0.2 mL
FOXQ1, ID (FOXQ1, HFH1, Forkhead box protein Q1, HNF-3/forkhead-like protein 1, Hepatocyte nuclear factor 3 forkhead homolog 1) (Azide free) (HRP)
Ask
View Details MBS6300030-02 5x 0.2 mL
FOXQ1, ID (FOXQ1, HFH1, Forkhead box protein Q1, HNF-3/forkhead-like protein 1, Hepatocyte nuclear factor 3 forkhead homolog 1) (Azide free) (HRP)
Ask
View Details 